Your browser doesn't support javascript.
loading
Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors.
Caulfield, Jasmine I; Aizenbud, Lilach; Perdigoto, Ana Luisa; Meffre, Eric; Jilaveanu, Lucia; Michalek, Dominika A; Rich, Stephen S; Aizenbud, Yariv; Adeniran, Adebowale; Herold, Kevan C; Austin, Matthew R; Kluger, Harriet.
Afiliación
  • Caulfield JI; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Aizenbud L; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Perdigoto AL; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Meffre E; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Jilaveanu L; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Michalek DA; Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
  • Rich SS; Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
  • Aizenbud Y; Department of Mathematics, Program in Applied Mathematics, Yale University, New Haven, Connecticut, New Haven, Connecticut, USA.
  • Adeniran A; Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Herold KC; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Austin MR; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Kluger H; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA Harriet.Kluger@Yale.edu.
J Immunother Cancer ; 11(3)2023 03.
Article en En | MEDLINE | ID: mdl-36898736

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Insulinas / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Insulinas / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido